Memantine Hydrochloride Extended Release Capsules recall: Failed Dissolution
Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland…
Why was Memantine Hydrochloride Extended Release Capsules recalled?
Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: H900330, exp. date 11/2020.
- Product
- Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland…
- Recalling firm
- Lupin Pharmaceuticals Inc.
- Quantity
- 6,294 bottles
- Distribution
- Nationwide within the United States.
- Recall date
- February 19, 2020
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)